Author

C. Slade

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:differential expression· 1 Assay:flow cytometry· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Kume· 1 shared A. Poch· 1 shared A. Strasser· 1 shared A. W. Roberts· 1 shared C. A. Bricault· 1 shared C. E. Teh· 1 shared C. S. Tam· 1 shared C.-L. Hsieh· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Kume

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Early cytokine-driven adaptation of survival pathways in lymphoid cells during targeted therapies

M.-X. Luo, T. Tan, M. Trussart, A. Poch, M. H. T. Nguyen, T. P. Speed, D. G. Hicks, E. Bandala-Sanchez, H. Peng, S. Chappaz, C. Slade, D. T. Utzschneider, A. Strasser, R. Thijssen, M. E. Ritchie, , D. H. Gray

This study shows that CLL cells rapidly adapt to venetoclax by upregulating pro-survival proteins and cytokines, suggesting combination therapies targeting these pathways could improve treatment outcomes.

bioRxiv · Mar 4, 2024 · PreprintCancer Biology

Characterization of prefusion-F-specific antibodies elicited by natural infection with human metapneumovirus

S. A. Rush, G. Brar, C.-L. Hsieh, E. Chautard, J. N. Rainho-Tomko, C. Slade, C. A. Bricault, A. Kume, J. Kearns, R. Groppo, S. Mundle, L. Zhang, D. Casimiro, T.-M. Fu, J. M. DiNapoli, J. S. McLellan

This study characterizes prefusion-F-specific antibodies from elderly individuals naturally infected with hMPV, revealing their epitope recognition and neutralizing activity.

bioRxiv · Mar 28, 2022Immunology